All In MedTech

FDA Clearance Tracker · K022504

IDI-STREP B ASSAY

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Nov 18, 2002 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Nov 18, 2002

Substantially Equivalent

Time to decision

112 days

Received Jul 29, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class I

The decision

FDA number
K022504
Device name
IDI-STREP B ASSAY
Applicant location
Baldwin, MD
Received
Jul 29, 2002
Decided
Nov 18, 2002
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class I
Regulation
21 CFR 866.3740

Every decision under product code NJR

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NJR (Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K022504
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Infectio Diagnostic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.